All In MedTech

Device Trial Radar · NCT07714876

Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation

A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation - Post Approval Study

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Dec 2029

Study completion Dec 2031

Sponsor

Lead sponsor
Kardium Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 20, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long-term safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal atrial fibrillation.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

  • Globe Pulsed Field SystemDevice

    Ablation and atrial mapping with the Globe Pulsed Field System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 12-month Treatment Success RateTime frame: 12 months
  2. Primary Safety Event RateTime frame: 7 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Arrhythmia Research Group

    Jonesboro, Arkansas

  • Overlake Hospital

    Bellevue, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.